Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extended Evaluation of Recombinant Human Activated Protein C United States Trial (ENHANCE US)

Published:2004-06 Issue:6 Volume:125 Page:2206-2216
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Bernard Gordon R.,Margolis Benjamin D.,Shanies Harvey M.,Ely E. Wesley,Wheeler Arthur P.,Levy Howard,Wong Kar,Wright Theressa J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference26 articles.

1. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial;Angus;JAMA,2000

2. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units; French ICU Group for Severe Sepsis;Brun-Buisson;JAMA,1995

3. The epidemiology of sepsis in the United States from 1979 through 2000;Martin;N Engl J Med,2003

4. Efficacy and safety of recombinant human activated protein C for severe sepsis;Bernard;N Engl J Med,2001

5. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis;Bernard;Crit Care Med,2001

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sepsis-Induced Coagulopathy: A Comprehensive Narrative Review of Pathophysiology, Clinical Presentation, Diagnosis, and Management Strategies;Anesthesia & Analgesia;2024-02-07

2. Hemostasis;Lessons from the ICU;2023

3. General Aspects of Sepsis-Associated Coagulopathy;The Coagulation Labyrinth of Covid-19;2021-12-08

4. Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment;Blood Reviews;2021-11

5. Response to 'Pulmonary thrombosis in 2019‐nCoV pneumonia?';Journal of Thrombosis and Haemostasis;2020-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3